Age at baseline (mean ± SD years) |
79.41±5.12 |
82.15±5.55 |
79.66±5.20 |
t(501)=3.434, p=0.001 |
Education (mean ± SD years) |
11.12±4.86 |
7.70±5.01 |
10.58±4.37 |
t(499)=4.537, p<0.001 |
Race/Ethnicity |
% White/other |
30.2 |
21.7 |
29.6 |
χ2(2)=7.083, p=0.029 |
% African American |
33.2 |
21.7 |
32.1 |
% Hispanic |
36.5 |
56.5 |
38.3 |
APOE ε4 frequency |
24.4 |
22.7 |
24.3 |
χ2(1)=0.062, p=0.803 |
Vascular risk factors |
% Diabetes mellitus |
21.0 |
23.9 |
21.3 |
χ2(1)=0.211, p=0.646 |
% Hypertension |
69.1 |
65.2 |
68.8 |
χ2(1)=0.301, p=0.584 |
% Heart disease |
22.5 |
17.4 |
22.1 |
χ2(1)=0.644, p=0.422 |
% Stroke |
9.8 |
15.2 |
10.3 |
χ2(1)=1.300, p=0.254 |
Vascular history score (median) |
1 |
1 |
1 |
Mann-Whitney U = 10242.50, p=0.761 |
Time between MRI scan and baseline evaluation (mean ± SD months) |
0.96±5.27 |
1.61±7.05 |
0.79±6.25 |
t(499)=0.766, p=0.444 |
Time between MRI scan and follow-up visit (mean ± SD months) |
40.18±9.68 |
41.63±10.69 |
40.28±9.77 |
t(474)=0.911, p=0.363 |
Regional WMH volume (mean ± SD cm3) |
Frontal |
1.69±3.19 |
2.04±2.84 |
1.70±3.16 |
Diagnostic Group: F(1,441)=0.258, p=0.612), Group by Region: F(3,1323)=0.534, p=0.659) |
Temporal |
0.12±0.28 |
0.13±0.23 |
0.12±0.27 |
Parietal |
1.24±2.48 |
1.77±2.55 |
1.29±2.49 |
Occipital |
0.16±0.38 |
0.13±0.17 |
0.15±0.37 |
Relative hippocampus volume |
0.29±0.06 |
0.28±0.07 |
0.29±0.06 |
F(1,435)=0.339, p=0.561 |